Literature DB >> 30782976

Dopamine Release Dynamics in the Tuberoinfundibular Dopamine System.

Stefanos Stagkourakis1, Johan Dunevall2, Zahra Taleat3, Andrew G Ewing3, Christian Broberger1.   

Abstract

The relationship between neuronal impulse activity and neurotransmitter release remains elusive. This issue is especially poorly understood in the neuroendocrine system, with its particular demands on periodically voluminous release of neurohormones at the interface of axon terminals and vasculature. A shortage of techniques with sufficient temporal resolution has hindered real-time monitoring of the secretion of the peptides that dominate among the neurohormones. The lactotropic axis provides an important exception in neurochemical identity, however, as pituitary prolactin secretion is primarily under monoaminergic control, via tuberoinfundibular dopamine (TIDA) neurons projecting to the median eminence (ME). Here, we combined electrical or optogenetic stimulation and fast-scan cyclic voltammetry to address dopamine release dynamics in the male mouse TIDA system. Imposing different discharge frequencies during brief (3 s) stimulation of TIDA terminals in the ME revealed that dopamine output is maximal at 10 Hz, which was found to parallel the TIDA neuron action potential frequency distribution during phasic discharge. Over more sustained stimulation periods (150 s), maximal output occurred at 5 Hz, similar to the average action potential firing frequency of tonically active TIDA neurons. Application of the dopamine transporter blocker, methylphenidate, significantly increased dopamine levels in the ME, supporting a functional role of the transporter at the neurons' terminals. Lastly, TIDA neuron stimulation at the cell body yielded perisomatic release of dopamine, which may contribute to an ultrafast negative feedback mechanism to constrain TIDA electrical activity. Together, these data shed light on how spiking patterns in the neuroendocrine system translate to vesicular release toward the pituitary and identify how dopamine dynamics are controlled in the TIDA system at different cellular compartments.SIGNIFICANCE STATEMENT A central question in neuroscience is the complex relationship between neuronal discharge activity and transmitter release. By combining optogenetic stimulation and voltammetry, we address this issue in dopamine neurons of the neuroendocrine system, which faces particular spatiotemporal demands on exocytotic release; large amounts of neurohormone need to be secreted into the portal capillaries with precise timing to adapt to physiological requirements. Our data show that release is maximal around the neurons' default firing frequency. We further provide support for functional dopamine transport at the neurovascular terminals, shedding light on a long-standing controversy about the existence of neuroendocrine transmitter reuptake. Finally, we show that dopamine release occurs also at the somatodendritic level, providing a substrate for an ultrashort autoregulatory feedback loop.
Copyright © 2019 the authors.

Entities:  

Keywords:  FSCV; arcuate nucleus; dopamine release; frequency coding; hypothalamus; tuberoinfundibular

Year:  2019        PMID: 30782976      PMCID: PMC6529860          DOI: 10.1523/JNEUROSCI.2339-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  Quantal components of the end-plate potential.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

2.  Electrical stimulation of the hypothalamus and the mechanism of neural control of the adenohypophysis.

Authors:  G W Harris
Journal:  J Physiol       Date:  1948-09-30       Impact factor: 5.182

3.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

4.  Dopamine transporters participate in the physiological regulation of prolactin.

Authors:  J E Demaria; G M Nagy; A A Lerant; M I Fekete; C W Levenson; M E Freeman
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

5.  Effect of D2 dopamine agonists on tuberoinfundibular dopamine neurons.

Authors:  S A Berry; G A Gudelsky
Journal:  Neuropharmacology       Date:  1991-09       Impact factor: 5.250

6.  Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.

Authors:  N D Volkow; G J Wang; J S Fowler; M Fischman; R Foltin; N N Abumrad; S J Gatley; J Logan; C Wong; A Gifford; Y S Ding; R Hitzemann; N Pappas
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 7.  The prolactin/growth hormone receptor family: structure/function relationships.

Authors:  V Goffin; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

8.  Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain.

Authors:  N D Volkow; J S Fowler; S J Gatley; S L Dewey; G J Wang; J Logan; Y S Ding; D Franceschi; A Gifford; A Morgan; N Pappas; P King
Journal:  Synapse       Date:  1999-01       Impact factor: 2.562

Review 9.  Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo.

Authors:  Donita L Robinson; B Jill Venton; Michael L A V Heien; R Mark Wightman
Journal:  Clin Chem       Date:  2003-10       Impact factor: 8.327

10.  Effect of Dopamine Agonists on Lactotroph Adenomas of the Human Pituitary.

Authors:  Lucia Stefaneanu; Kalman Kovacs; Bernd W. Scheithauer; George Kontogeorgos; Darren L. Riehle; Thomas J. Sebo; David Murray; Sergio Vidal; Ami Tran; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

View more
  7 in total

1.  Trpc5 deficiency causes hypoprolactinemia and altered function of oscillatory dopamine neurons in the arcuate nucleus.

Authors:  Thomas Blum; Ana Moreno-Pérez; Martina Pyrski; Bernd Bufe; Anela Arifovic; Petra Weissgerber; Marc Freichel; Frank Zufall; Trese Leinders-Zufall
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

2.  The dopamine membrane transporter plays an active modulatory role in synaptic dopamine homeostasis.

Authors:  Rosaria Formisano; Katarzyna D Rosikon; Abhyudai Singh; Harbinder S Dhillon
Journal:  J Neurosci Res       Date:  2021-11-08       Impact factor: 4.433

Review 3.  Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies.

Authors:  Milena Stojkovic; Branimir Radmanovic; Mirjana Jovanovic; Vladimir Janjic; Nemanja Muric; Dragana Ignjatovic Ristic
Journal:  Front Psychiatry       Date:  2022-05-06       Impact factor: 5.435

4.  Taurine and coenzyme Q10 synergistically prevent and reverse chlorpromazine-induced psycho-neuroendocrine changes and cataleptic behavior in rats.

Authors:  Mega O Oyovwi; Eze K Nwangwa; Benneth Ben-Azu; Tesi P Edesiri; Victor Emojevwe; John C Igweh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-04       Impact factor: 3.000

5.  Off-Target Effects in Transgenic Mice: Characterization of Dopamine Transporter (DAT)-Cre Transgenic Mouse Lines Exposes Multiple Non-Dopaminergic Neuronal Clusters Available for Selective Targeting within Limbic Neurocircuitry.

Authors:  Maria Papathanou; Sylvie Dumas; Hanna Pettersson; Lars Olson; Åsa Wallén-Mackenzie
Journal:  eNeuro       Date:  2019-10-31

6.  Dopamine Increases the Intrinsic Excitability of Parvalbumin-Expressing Fast-Spiking Cells in the Piriform Cortex.

Authors:  Yasmin Potts; John M Bekkers
Journal:  Front Cell Neurosci       Date:  2022-06-09       Impact factor: 6.147

Review 7.  Distinct cell populations of ventral tegmental area process motivated behavior.

Authors:  Min Jung Kim; Bong-Kiun Kaang
Journal:  Korean J Physiol Pharmacol       Date:  2022-09-01       Impact factor: 1.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.